Skip to content
MedsAcross

Medicine

Anticoagulant Citrate Dextrose A 0.073 g/0.245 g/0.22 g per 10 mL solution

Anhydrous citric acid, Dextrose and Trisodium · Extracorporeal · Citra Labs
Available on requestPrescription onlyUS FDA

Anticoagulant Citrate Dextrose A 0.073 g/0.245 g/0.22 g per 10 mL solution is a prescription medicine containing Anhydrous citric acid, Dextrose and Trisodium for extracorporeal use, marketed by Citra Labs, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.

Availability

Available on request

Export supply from India to licensed buyers

Typical lead time

On request

Counted from payment and complete documents

Shipping

Ambient

Protect from freezing and exposure to excessive heat should be minimized. It…

Key facts

Active ingredient (INN)
Anhydrous citric acid, Dextrose and Trisodium
Brand
Anticoagulant Citrate Dextrose A
Strength
0.073 g/0.245 g/0.22 g per 10 mL
Dosage form
Solution
Route
Extracorporeal
Packs
10 vials, 25 vials, 30 mL
Marketing authorisation holder
Citra Labs
Manufacturer
Citra Labs
Origin register
US FDA, United States
Storage
Protect from freezing and exposure to excessive heat should be minimized. It is recommended that the product be stored at ambient room temperature, 24 °C (75 °F), however, the product can be stored between 15 °C (59 °F) and 30 °C (86 °F).
Cold chain
Not required on record
Prescription status
Prescription only
Controlled substance
Not recorded as controlled
HS code (indicative)
3004.90Indicative only. Your customs broker confirms the final tariff code.
Marketing category
marketed
Marketed since
26 August 2003
Identifiers
DailyMed set ID 5bcd261e-ebba-4ecb-af22-e5aaeb04499bNDC 23731-6051Application BN020037

Record updated 12 November 2026

Documents available

Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.

No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.

Packs

PackCodeLabelerMarketed since
10 vial, single-use in 1 case / 30 mL in 1 vial, single-use23731-6051-1Citra Labs26 August 2003
25 vial, single-use in 1 case / 30 mL in 1 vial, single-use23731-6051-2Citra Labs26 August 2003
30 mL in 1 vial, single-use23731-6051-3Citra Labs26 August 2003

Status by register

Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.

RegisterStatusSource
US FDAListed, marketedSource record for this pageChecked 12 November 2026
EU (EMA)Not recorded—
India (CDSCO)Not yet confirmed against CDSCO approval lists—
United StatesRegisteredUS FDA (NDC directory, openFDA)Checked 12 November 2026

Import route

Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.

Import guides are available for 25 countries. Pick one to see its route summary.

BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides

Other strengths and forms of Anhydrous citric acid, Dextrose and Trisodium

Clinical summary

Anhydrous citric acid, Dextrose and Trisodium is a fixed-dose combination of an anti-coagulant and a calculi dissolution agent. It is available as injection and solution for extracorporeal and intravenous use. MedsAcross supplies Anhydrous citric acid, Dextrose and Trisodium for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.

Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review

Read about Anhydrous citric acid, Dextrose and Trisodium

For healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.

Data sources

Need Anticoagulant Citrate Dextrose A 0.073 g/0.245 g/0.22 g per 10 mL solution for your hospital or patient?

Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.